JAMA Medical News

Епизоде

• 
  The Challenge of Diagnosing Adult ADHD 18.09.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right." Related Content: As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right
• 
  Researchers Turn to Viruses to Treat UTIs 11.09.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Is Phage Therapy the Next Big Hope for Urinary Tract Infections?" Related Content: Is Phage Therapy the Next Big Hope for Urinary Tract Infections?
• 
  A New Definition of MI and Other Heart Health Highlights From ESC Congress 2026 11.09.2026 25мин

  Hear about a new universal definition of myocardial infarction, updated heart failure guidelines, and other clinical highlights in this interview with Tomasz Guzik, MD, PhD, chair of this year's European Society of Cardiology Congress. Related Content: A New Universal Definition of MI, Blood Pressure and Dementia, and More News From ESC Congress 2026
• 
  The Fascinating Road to a New Narcolepsy Treatment 09.09.2026 38мин

  The winners of the 2026 Albert Lasker Basic Medical Research Award, Emmanuel Mignot, MD, PhD, and Masashi Yanagisawa, MD, PhD, discuss how they identified the neuropeptide orexin and deduced its role in narcolepsy. Related Content: How the Albert Lasker Winners Identified Orexin and Elucidated the Peptide's Role in Narcolepsy
• 
  What the Latest Research Says About Preventing Dementia 04.09.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Nearly Half of Dementia Cases May Be Preventable—Here's What the Research Says So Far." Related Content: Nearly Half of Dementia Cases May Be Preventable—Here's What the Research Says So Far
• 
  Considering Cognition and Frailty in Cardiovascular Care—Too Big an Ask? 28.08.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement." Related Content: Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement
• 
  The Tip of the Iceberg Lettuce 21.08.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What the Cyclospora Outbreak Reveals About the State of US Foodborne Disease Surveillance." Related Content: What the Cyclospora Outbreak Reveals About the State of US Foodborne Disease Surveillance
• 
  FDA Approves the First mRNA Flu Vaccine for the US 14.08.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA." Related Content: What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA
• 
  The Slow Evolution of Lyme Disease Care 07.08.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Will New Lyme Disease Approaches Change Patient Care?" Related Content: Will New Lyme Disease Approaches Change Patient Care?
• 
  Highlights From the 2026 Alzheimer's Association International Conference 31.07.2026 30мин

  Hear the latest on blood-based biomarkers, lifestyle interventions, and more from AAIC 2026 with Gil Rabinovici, MD. Related Content: Soccer Players' Brains, P-Tau217 Blood Tests, Lifestyle and Dementia Risk, and More From AAIC 2026
• 
  Striking the Balance for Prescribing Opioids 31.07.2026 5мин

  JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?" Related Content: A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?
• 
  The Menopause Treatment Boom 24.07.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace." Related Content: Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace
• 
  The First CKM Syndrome Guidelines Are Here 17.07.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines." Related Content: What to Know About the First CKM Syndrome Guidelines
• 
  The Testosterone Therapy Debate 10.07.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?" Related Content: Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?
• 
  Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected 02.07.2026 5мин

  JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds." Related Content: First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds
• 
  PMOS is the New PCOS 26.06.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?" Related Content: PCOS Is Now PMOS—Will a New Name Translate to Improved Clinical Care?
• 
  New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions 18.06.2026 22мин

  Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026
• 
  Why Exercise Still Matters in the GLP-1 Drug Era 18.06.2026 4мин

  JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA
• 
  The Search for a Fentanyl Vaccine 12.06.2026 5мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: Inside the Push for a Fentanyl Vaccine
• 
  New Insights on HFpEF in Patients With Severe Obesity 05.06.2026 4мин

  JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: HFpEF May Be a Different Disease in Patients With Severe Obesity